Cytokine-associated fatigue prior to, during, and post-chemotherapy for breast cancer
- 24 June 2019
- journal article
- research article
- Published by Elsevier in Journal of Neuroimmunology
- Vol. 334, 577001
Abstract
No abstract availableFunding Information
- Evelyn F. McKnight Brain Research Foundation
- National Institutes of Health
- National Institute of Nursing Research (R01NR012667, R01NR013932)
- University of Florida
- National Institute on Aging (R01AG054077)
This publication has 77 references indexed in Scilit:
- The interleukin-6 receptor as a target for prevention of coronary heart disease: a mendelian randomisation analysisThe Lancet, 2012
- IL-2 family cytokines: new insights into the complex roles of IL-2 as a broad regulator of T helper cell differentiationCurrent Opinion in Immunology, 2011
- Inflammation and Behavioral Symptoms After Breast Cancer Treatment: Do Fatigue, Depression, and Sleep Disturbance Share a Common Underlying Mechanism?Journal of Clinical Oncology, 2011
- An Update on Cancer- and Chemotherapy-Related Cognitive Dysfunction: Current StatusSeminars in Oncology, 2011
- Fatigue and gene expression in human leukocytes: Increased NF-κB and decreased glucocorticoid signaling in breast cancer survivors with persistent fatigueBrain, Behavior, and Immunity, 2011
- The effect of symptom clusters on functional status and quality of life in women with breast cancerEuropean Journal of Oncology Nursing, 2010
- Replication by the Epistasis Project of the interaction between the genes for IL-6 and IL-10 in the risk of Alzheimer's diseaseJournal of Neuroinflammation, 2009
- Cytokine gene polymorphisms and fatigue in breast cancer survivors: Early findingsBrain, Behavior, and Immunity, 2008
- Twenty years of research on cytokine-induced sickness behaviorBrain, Behavior, and Immunity, 2007
- IL-7 Administration to Humans Leads to Expansion of CD8+ and CD4+ Cells but a Relative Decrease of CD4+ T-Regulatory CellsJournal of Immunotherapy, 2006